FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Laurent Degos

Research Profile

Disorders

Chemicals & Drugs

Physiology

Cell Differentiation

Procedures

Anatomy

Concepts & Ideas

Living Beings

Mouse

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Laurent Degos; Victor G Rodwin
Two faces of patient safety and care quality: a Franco-American comparison.
Emmanuel Raffoux; Audrey Cras; Christian Recher; Pierre-Yves Boëlle; Adrienne de Labarthe; Pascal Turlure; Jean-Pierre Marolleau; Oumedaly Reman; Claude Gardin; Maud Victor; Sébastien Maury; Philippe Rousselot; Jean-Valère Malfuson; Odile Maarek; Marie-Thérèse Daniel; Pierre Fenaux; Laurent Degos; Christine Chomienne; Sylvie Chevret; Hervé Dombret
Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome.
Lionel Adès; Agnès Guerci; Emmanuel Raffoux; M Sanz; Patrice Chevallier; Simona Lapusan; Christian Recher; Xavier Thomas; C Rayon; Sylvie Castaigne; Olivier Tournilhac; Stéphane de Botton; Norbert Ifrah; Jean-Yves Cahn; Eric Solary; Claude Gardin; Nathalie Fegeux; Dominique Bordessoule; Augustin Ferrant; Sandrine Meyer-Monard; Norbert Vey; Hervé Dombret; Laurent Degos; Sylvie Chevret; Pierre Fenaux
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Laurent Degos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Laurent Degos; Victor G Rodwin
Two faces of patient safety and care quality: a Franco-American comparison.
Health economics, policy, and law 2011;6(3):287-94.
2010: Emmanuel Raffoux; Audrey Cras; Christian Recher; Pierre-Yves Boëlle; Adrienne de Labarthe; Pascal Turlure; Jean-Pierre Marolleau; Oumedaly Reman; Claude Gardin; Maud Victor; Sébastien Maury; Philippe Rousselot; Jean-Valère Malfuson; Odile Maarek; Marie-Thérèse Daniel; Pierre Fenaux; Laurent Degos; Christine Chomienne; Sylvie Chevret; Hervé Dombret
Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome.
Oncotarget 2010;1(1):34-42.
2010: Lionel Adès; Agnès Guerci; Emmanuel Raffoux; M Sanz; Patrice Chevallier; Simona Lapusan; Christian Recher; Xavier Thomas; C Rayon; Sylvie Castaigne; Olivier Tournilhac; Stéphane de Botton; Norbert Ifrah; Jean-Yves Cahn; Eric Solary; Claude Gardin; Nathalie Fegeux; Dominique Bordessoule; Augustin Ferrant; Sandrine Meyer-Monard; Norbert Vey; Hervé Dombret; Laurent Degos; Sylvie Chevret; Pierre Fenaux
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience.
Blood 2010;115(9):1690-6.
2008: Lionel Adès; Miguel A Sanz; Sylvie Chevret; Pau Montesinos; Patrice Chevallier; Emmanuel Raffoux; Edo Vellenga; Agnès Guerci; Arnaud Pigneux; Francoise Huguet; C Rayon; Anne-Marie Stoppa; Javier de la Serna; Jean-Yves Cahn; Sandrine Meyer-Monard; Thomas Pabst; Xavier Thomas; Stéphane de Botton; Ricardo Parody; Juan Bergua; Thierry Lamy; Anne Vekhoff; Silvia Negri; Norbert Ifrah; Hervé Dombret; Augustin Ferrant; Dominique Bron; Laurent Degos; Pierre Fenaux
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results.
Blood 2008;111(3):1078-84.
2007: Laurent Delva; Arthur Zelent; Tomoki Naoe; Pierre Fenaux; Samuel Waxman; Laurent Degos; Christine Chomienne
Meeting report: the 11th International Conference on Differentiation Therapy and Innovative Therapeutics in Oncology.
Cancer research 2007;67(22):10635-7.
2007: Laurent Degos
[Self-medication, patients as actors in their own health].
Bulletin de l'Académie nationale de médecine 2007;191(8):1503-7; discussion 1507-8.
2007: Pierre Fenaux; Z Z Wang; Laurent Degos
Treatment of acute promyelocytic leukemia by retinoids.
Current topics in microbiology and immunology 2007;313():101-28.
2006: Lionel Adès; Sylvie Chevret; Emmanuel Raffoux; Stéphane de Botton; Agnès Guerci; Arnaud Pigneux; Anne-Marie Stoppa; Thierry Lamy; Françoise Rigal-Huguet; Anne Vekhoff; Sandrine Meyer-Monard; Frédéric Maloisel; Eric DECONINCK; Augustin Ferrant; Xavier Thomas; Nathalie Fegueux; Christine Chomienne; Hervé Dombret; Laurent Degos; Pierre Fenaux
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5703-10.
2006: C Kelaidi; Lionel Ades; Sylvie Chevret; M Sanz; Agnès Guerci; Xavier Thomas; Stéphane de Botton; Emmanuel Raffoux; C Rayon; Nathalie Fegueux; Dominique Bordessoule; Françoise Rigal-Huguet; H Link; Anne-Marie Stoppa; Anne Vekhoff; Sandrine Meyer-Monard; Sylvie Castaigne; Hervé Dombret; Laurent Degos; Pierre Fenaux
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials).
Leukemia 2006;20(5):905-7.
2006: Stéphane de Botton; M A Sanz; Sylvie Chevret; Hervé Dombret; G Martin; Xavier Thomas; J D Mediavilla; Christian Recher; Lionel Ades; Bruno Quesnel; P Brault; Martin Fey; H Wandt; D Machover; Agnès Guerci; Frédéric Maloisel; Anne-Marie Stoppa; C Rayon; J M Ribera; Christine Chomienne; Laurent Degos; Pierre Fenaux
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
Leukemia 2006;20(1):35-41.
2005: Emmanuel Raffoux; Pascal Chaibi; Hervé Dombret; Laurent Degos
Valproic acid and all-trans retinoic acid for the treatment of elderly patients with acute myeloid leukemia.
Haematologica 2005;90(7):986-8.
2005: Arthur Zelent; Kevin Petrie; Zhu Chen; Reuben Lotan; Michael Lübbert; Martin S Tallman; Ryuzo Ohno; Laurent Degos; Samuel Waxman
Molecular target-based treatment of human cancer: summary of the 10th international conference on differentiation therapy.
Cancer research 2005;65(4):1117-23.
2005: Lionel Ades; Sylvie Chevret; Stéphane de Botton; Xavier Thomas; Hervé Dombret; B Beve; M Sanz; Agnès Guerci; JS Miguel; J Dela Serna; C Garo; Anne-Marie Stoppa; Oumedaly Reman; A Stamatoulas; Martin Fey; Jean-Yves Cahn; Jean-Jacques Sotto; Jean-Henri Bourhis; A Parry; Christine Chomienne; Laurent Degos; Pierre Fenaux
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience.
Leukemia 2005;19(2):230-3.
2005: Stéphane de Botton; A Fawaz; Sylvie Chevret; Hervé Dombret; Xavier Thomas; M Sanz; Agnès Guerci; Jesús San Miguel; Javier de la Serna; Anne-Marie Stoppa; Oumedaly Reman; A Stamatoulas; Martin Fey; Jean-Yves Cahn; Jean-Jacques Sotto; Jean-Henri Bourhis; A Parry; Christine Chomienne; Laurent Degos; Pierre Fenaux
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(1):120-6.
2004: Sylvie Castaigne; Sylvie Chevret; Eric Archimbaud; Pierre Fenaux; Dominique Bordessoule; Hervé Tilly; Thierry de Revel; Marc Simon; Brigitte Dupriez; Michel Renoux; Maud Janvier; Jean-Michel Micléa; Xavier Thomas; Christian Bastard; Claude Preudhomme; Francis Bauters; Laurent Degos; Hervé Dombret
Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study.
Blood 2004;104(8):2467-74.
2004: Nicolas Boissel; Philippe Rousselot; Emmanuel Raffoux; Jean-Michel Cayuela; Odile Maarek; Dominique Charron; Laurent Degos; Hervé Dombret; Antoine Toubert; Delphine Rea
Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate.
Leukemia 2004;18(10):1656-61.
2004: Laurent Degos
[Future vision of haematology].
Presse médicale (Paris, France : 1983) 2004;33 Spec No():Sp64-6.
2004: Stéphane de Botton; Valérie Coiteux; Sylvie Chevret; C Rayon; E Vilmer; M Sanz; Javier de la Serna; Noël Philippe; André Baruchel; G Leverger; A Robert; Jesús San Miguel; Eulogio Conde; Jean-Jacques Sotto; Dominique Bordessoule; Nathalie Fegueux; Martin Fey; A Parry; Christine Chomienne; Laurent Degos; Pierre Fenaux
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(8):1404-12.
2004: Olivier Hermine; Hervé Dombret; Joël Poupon; Bertrand Arnulf; François Lefrère; Philippe Rousselot; Gandhi Damaj; Richard Delarue; Jean-Paul Fermand; Jean-Claude Brouet; Laurent Degos; Bruno Varet; Hugues de Thé; Ali Bazarbachi
Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(2):130-4.
2003: Jérôme Larghero; Thibaut Leguay; SAMIA MOURAH; Isabelle Madelaine-Chambrin; Anne-Laure Taksin; Emmanuel Raffoux; Jean-Noël Bastie; Laurent Degos; Patrice Berthaud; Jean-Pierre Marolleau; Fabien Calvo; Christine Chomienne; François-Xavier Mahon; Philippe Rousselot
Relationship between elevated levels of the alpha 1 acid glycoprotein in chronic myelogenous leukemia in blast crisis and pharmacological resistance to imatinib (Gleevec) in vitro and in vivo.
Biochemical pharmacology 2003;66(10):1907-13.
2003: Rose Ann Padua; Jérôme Larghero; Marie Robin; Carole le Pogam; Marie-Hélène Schlageter; Sacha Muszlak; Fric Jan; Robert R West; Philippe Rousselot; Thi Hai Phan; Liesbeth Mudde; Helene Teisserenc; Antoine F Carpentier; Scott C Kogan; Laurent Degos; Marika Pla; John M Bishop; Freda Stevenson; Dominique Charron; Christine Chomienne
PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia.
Nature medicine 2003;9(11):1413-7.
2003: Laurence Michel; Alain Dupuy; Francette Jean-Louis; Aurore Sors; Joël Poupon; Manuelle Viguier; Philippe Musette; Louis Dubertret; Laurent Degos; Hervé Dombret; Hervé Bachelez
Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C).
The Journal of investigative dermatology 2003;121(4):881-93.
2003: Laurent Degos
The history of acute promyelocytic leukaemia.
British journal of haematology 2003;122(4):539-53.
2003: I Lobe; Françoise Rigal-Huguet; Anne Vekhoff; Bernard Desablens; Dominique Bordessoule; C Mounier; Augustin Ferrant; M Sanz; Martin Fey; Christine Chomienne; Sylvie Chevret; Laurent Degos; Pierre Fenaux
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
Leukemia 2003;17(8):1600-4.
2003: Emmanuel Raffoux; Philippe Rousselot; Joël Poupon; Marie-Thérèse Daniel; Bruno Cassinat; Richard Delarue; Anne-Laure Taksin; Delphine Réa; Agnès Buzyn; Annick Tibi; Geneviève Lebbé; Patricia Cimerman; Christine Chomienne; Jean-Paul Fermand; Hugues de Thé; Laurent Degos; Olivier Hermine; Hervé Dombret
Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(12):2326-34.
2003: Stéphane de Botton; Sylvie Chevret; Valérie Coiteux; Hervé Dombret; M Sanz; Jesús San Miguel; Denis Caillot; Anne Vekhoff; Martine Gardembas; A Stamatoulas; Eulogio Conde; Agnès Guerci; Claude Gardin; Martin Fey; D Cony Makhoul; Oumedaly Reman; Javier de la Serna; F Lefrere; Christine Chomienne; Laurent Degos; Pierre Fenaux
Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial.
Leukemia 2003;17(2):339-42.
2002: Marie-Claude Guillemin; Emmanuel Raffoux; Dominique VITOUX; Scott C Kogan; Hassane Soilihi; Valérie Lallemand-Breitenbach; Jun Zhu; Anne Janin; Marie-Thérèse Daniel; Bernard Gourmel; Laurent Degos; Hervé Dombret; Michel Lanotte; Hugues de Thé
In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia.
The Journal of experimental medicine 2002;196(10):1373-80.
2002: Nicolas Boissel; Jean-Michel Cayuela; Claude Preudhomme; Xavier Thomas; Nathalie Grardel; Xavier Fund; Isabelle Tigaud; Emmanuel Raffoux; Philippe Rousselot; François Sigaux; Laurent Degos; Sylvie Castaigne; Pierre Fenaux; Hervé Dombret
Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy.
Leukemia 2002;16(9):1699-704.
2002: Laurent Degos
[Caring for a patient and not a disease isolated in its context].
La Revue du praticien 2002;52(8):817-8.
2002: Heinz Ludwig; Kanti Rai; Joan Blade; Franco Dammacco; Laurent Degos; Loretta Itri; Robert Kyle; Vicenzo Liso; Timothy James Littlewood; Franco Mandelli; Giovanna Meloni; Stefano Molica; Anders Osterborg; Gerassimos A Pangalis; Jesús San Miguel; Barbara Schmitt; Dimitrios Voliotis
Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations.
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(3):121-30.
2001: Bruno Cassinat; Sylvie Chevret; Fabien Zassadowski; Nicole Balitrand; Isabelle Guillemot; Marie-Laurence Menot; Laurent Degos; Pierre Fenaux; Christine Chomienne
In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome.
Blood 2001;98(9):2862-4.
2001: Laurent Degos; Z Y Wang
All trans retinoic acid in acute promyelocytic leukemia.
Oncogene 2001;20(49):7140-5.
2000: Anne Thiebaut; Jean-Paul Vernant; Laurent Degos; Francoise Huguet; Josy Reiffers; Catherine Sebban; E Lepage; Xavier Thomas; Denis Fière
Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.
Hematology/oncology clinics of North America 2000;14(6):1353-66, x.
2000: Stéphane de Botton; Sylvie Chevret; M Sanz; Hervé Dombret; Xavier Thomas; Agnès Guerci; Martin Fey; C Rayon; Francoise Huguet; Jean-Jacques Sotto; Claude Gardin; Pascale Cony-Makhoul; Philippe Travade; Eric Solary; Nathalie Fegueux; Dominique Bordessoule; Jesús San Miguel; H Link; Bernard Desablens; Aspasia Stamatoullas; Eric DECONINCK; K Geiser; Urs Hess; Frédéric Maloisel; Sylvie Castaigne; Claude Preudhomme; Christine Chomienne; Laurent Degos; Pierre Fenaux
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial.
British journal of haematology 2000;111(3):801-6.
2000: C Adida; Christian Recher; Emmanuel Raffoux; Marie-Thérèse Daniel; Anne-Laure Taksin; Philippe Rousselot; François Sigaux; Laurent Degos; Dario C Altieri; Hervé Dombret
Expression and prognostic significance of survivin in de novo acute myeloid leukaemia.
British journal of haematology 2000;111(1):196-203.
2000: Pierre Fenaux; Sylvie Chevret; Agnès Guerci; Nathalie Fegueux; Hervé Dombret; Xavier Thomas; M Sanz; H Link; Frédéric Maloisel; Claude Gardin; Dominique Bordessoule; Anne-Marie Stoppa; Alain Sadoun; P Muus; H Wandt; P Mineur; J A Whittaker; Martin Fey; Marie-Thérèse Daniel; Sylvie Castaigne; Laurent Degos
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group.
Leukemia 2000;14(8):1371-7.
2000: Xavier Thomas; Hervé Dombret; Catherine Cordonnier; Arnaud Pigneux; Claude Gardin; Agnès Guerci; Anne Vekhoff; Alain Sadoun; Aspasia Stamatoullas; Nathalie Fegueux; Frédéric Maloisel; Jean-Yves Cahn; Oumedaly Reman; Nicole Gratecos; Christian Berthou; Francoise Huguet; P Kotoucek; Philippe Travade; Agnès Buzyn; Thierry de Revel; Jean-Pierre Vilque; P Naccache; Christine Chomienne; Laurent Degos; Pierre Fenaux
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
Leukemia 2000;14(6):1006-13.
2000: Bruno Cassinat; Fabien Zassadowski; Nicole Balitrand; C Barbey; Jean-Didier Rain; Pierre Fenaux; Laurent Degos; Michel Vidaud; Christine Chomienne
Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR.
Leukemia 2000;14(2):324-8.
2000: Nicolas Da Silva; Sandrine Meyer-Monard; Marie-Laurence Menot; Antonio Parrado; A Lebel; Nicole Balitrand; Pierre Fenaux; Jean-Michel Micléa; Philippe Rousselot; Laurent Degos; Hervé Dombret; Christine Chomienne
Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(5):316-28.
1999: Jean-Noël Bastie; D Cazals-Hatem; Marie-Thérèse Daniel; M F D'Agay; C Rabian; S Glaisner; M P Noel-Walter; D Dabout; G Flandrin; Hervé Dombret; D Poisson; Laurent Degos; Sylvie Castaigne
Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
Leukemia & lymphoma 1999;35(5-6):555-65.
1999: Pierre Fenaux; C Chastang; Sylvie Chevret; M Sanz; Hervé Dombret; Eric Archimbaud; Martin Fey; C Rayon; Francoise Huguet; Jean-Jacques Sotto; Claude Gardin; P C Makhoul; Philippe Travade; Eric Solary; Nathalie Fegueux; Dominique Bordessoule; JS Miguel; H Link; Bernard Desablens; Aspasia Stamatoullas; Eric DECONINCK; Frédéric Maloisel; Sylvie Castaigne; Claude Preudhomme; Laurent Degos
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group.
Blood 1999;94(4):1192-200.
1999: Jérôme Larghero; Fabien Zassadowski; Philippe Rousselot; Rose Ann Padua; Laurent Degos; Christine Chomienne
Alteration of the PML proto-oncogene in leukemic cells does not abrogate expression of MHC class I antigens.
Leukemia 1999;13(8):1295-6.
1999: Antoine F Carpentier; N Leonard; Joëlle Lacombe; Fabien Zassadowski; Rose Ann Padua; Laurent Degos; Catherine Daumas-Duport; Christine Chomienne
Retinoic acid modulates RAR alpha and RAR beta receptors in human glioma cell lines.
Anticancer research 1999;19(4B):3189-92.
1999: Laurent Degos
[Discovery of the HLA system].
La Revue du praticien 1999;49(9):920-2.
1999: Valérie Lallemand-Breitenbach; Marie-Claude Guillemin; Anne Janin; Marie-Thérèse Daniel; Laurent Degos; Scott C Kogan; John M Bishop; Hugues de Thé
Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia.
The Journal of experimental medicine 1999;189(7):1043-52.
1999: Marcel Koken; Marie-Thérèse Daniel; Maurizio Gianni; Arthur Zelent; J Licht; Agnès Buzyn; P Minard; Laurent Degos; B Varet; Hugues de Thé
Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient.
Oncogene 1999;18(4):1113-8.
1998: Stéphane de Botton; Hervé Dombret; M Sanz; JS Miguel; Denis Caillot; R Zittoun; Martine Gardembas; A Stamatoulas; E Condé; Agnès Guerci; Claude Gardin; K Geiser; D C Makhoul; Oumedaly Reman; Javier de la Serna; F Lefrere; Christine Chomienne; C Chastang; Laurent Degos; Pierre Fenaux
Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
Blood 1998;92(8):2712-8.
1997: Laurent Degos
Differentiation therapy in acute promyelocytic leukemia: European experience.
Journal of cellular physiology 1997;173(2):285-7.
1997: A Carpentier; Nicole Balitrand; Cécile Rochette-Egly; B Shroot; Laurent Degos; Christine Chomienne
Distinct sensitivity of neuroblastoma cells for retinoid receptor agonists: evidence for functional receptor heterodimers.
Oncogene 1997;15(15):1805-13.
1997: Nicolas Da Silva; Sandrine Meyer-Monard; Marie-Laurence Menot; Laurent Degos; André Baruchel; Hervé Dombret; Christine Chomienne
G-CSF activates STAT pathways in Kasumi-1 myeloid leukemic cells with the t(8; 21) translocation: basis for potential therapeutic efficacy.
Cytokines, cellular & molecular therapy 1997;3(2):75-80.
1997: Jun Zhu; Marcel Koken; F Quignon; Mounira K Chelbi-Alix; Laurent Degos; wang zhenyi; Zhu Chen; Hugues de Thé
Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(8):3978-83.
1997: Pierre Fenaux; Christine Chomienne; Laurent Degos
Acute promyelocytic leukemia: biology and treatment.
Seminars in oncology 1997;24(1):92-102.
1996: C Andre; Marie-Claude Guillemin; Jun Zhu; Marcel Koken; F Quignon; L Herve; Mounira K Chelbi-Alix; D Dhumeaux; wang zhenyi; Laurent Degos; Z Chen; H de The
The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic.
Experimental cell research 1996;229(2):253-60.
1996: Christine Chomienne; Pierre Fenaux; Laurent Degos
Retinoid differentiation therapy in promyelocytic leukemia.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1996;10(9):1025-30.
1996: J Seale; L Delva; P Renesto; Nicole Balitrand; Hervé Dombret; M L Scrobohaci; Laurent Degos; P Paul; Christine Chomienne
All-trans retinoic acid rapidly decreases cathepsin G synthesis and mRNA expression in acute promyelocytic leukemia.
Leukemia 1996;10(1):95-101.
1995: Mounira K Chelbi-Alix; L Pelicano; F Quignon; Marcel Koken; L Venturini; M Stadler; J Pavlovic; Laurent Degos; Hugues de Thé
Induction of the PML protein by interferons in normal and APL cells.
Leukemia 1995;9(12):2027-33.
1995: A Agadir; M Cornic; P Lefebvre; Bernard Gourmel; M Jérôme; Laurent Degos; Pierre Fenaux; Christine Chomienne
All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: intracellular concentrations and biologic response relationship.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(10):2517-23.
1995: Hervé Dombret; S Geiger; Marie-Thérèse Daniel; S Glaisner; J M Micléa; Sylvie Castaigne; H Merle-Beral; C Lacombe; Christine Chomienne; Laurent Degos
Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?
Leukemia 1995;9(9):1473-7.
1995: Jean Soulier; L Grollet; Eric Oksenhendler; P Cacoub; Dominique Cazals-Hatem; P Babinet; M F d'Agay; jean pierre clauvel; M Raphael; Laurent Degos
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.
Blood 1995;86(4):1276-80.
1995: A Agadir; M Cornic; M Jérôme; Marie-Laurence Menot; Nathalie Cambier; M P Gaub; Bernard Gourmel; P Lefebvre; Laurent Degos; Christine Chomienne
Characterization of nuclear retinoic acid binding activity in sensitive leukemic cell lines: cell specific uptake of ATRA and RAR alpha protein modulation.
Biochemical and biophysical research communications 1995;213(1):112-22.
1995: Laurent Degos; Hervé Dombret; Christine Chomienne; Marie-Thérèse Daniel; J M Micléa; C Chastang; Sylvie Castaigne; Pierre Fenaux
All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.
Blood 1995;85(10):2643-53.
1995: P Lefebvre; A Agadir; M Cornic; Bernard Gourmel; B Hue; C Dreux; Laurent Degos; Christine Chomienne
Simultaneous determination of all-trans and 13-cis retinoic acids and their 4-oxo metabolites by adsorption liquid chromatography after solid-phase extraction.
Journal of chromatography. B, Biomedical applications 1995;666(1):55-61.
1995: Marcel Koken; G Linares-Cruz; F Quignon; A Viron; Mounira K Chelbi-Alix; J Sobczak-Thépot; L Juhlin; Laurent Degos; F Calvo; Hugues de Thé
The PML growth-suppressor has an altered expression in human oncogenesis.
Oncogene 1995;10(7):1315-24.
1995: Eric Jourdan; Hervé Dombret; S Glaisner; J M Micléa; Sylvie Castaigne; Laurent Degos
Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy for acute myeloid leukaemia with a monoblastic component.
British journal of haematology 1995;89(3):527-30.
1995: Pierre Fenaux; C Chastang; Christine Chomienne; Sylvie Castaigne; M Sanz; H Link; B Löwenberg; M Fey; E Archim-Baud; Laurent Degos
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group.
Leukemia & lymphoma 1995;16(5-6):431-7.
1995: A Agadir; M Cornic; P Lefebvre; Bernard Gourmel; Nicole Balitrand; Laurent Degos; Christine Chomienne
Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: evidence for its role in retinoic acid efficacy.
Leukemia 1995;9(1):139-45.
1995: Hervé Dombret; M L Scrobohaci; Marie-Thérèse Daniel; J M Micléa; Sylvie Castaigne; Christine Chomienne; Pierre Fenaux; Laurent Degos
In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
Leukemia 1995;9(1):19-24.
1994: M Cornic; A Agadir; Laurent Degos; Christine Chomienne
Retinoids and differentiation treatment: a strategy for treatment in cancer.
Anticancer research 1994;14(6A):2339-46.
1994: A de Gentile; Marie-Elisabeth Toubert; C Dubois; I Krawice; Marie-Hélène Schlageter; Nicole Balitrand; Sylvie Castaigne; Laurent Degos; Jean-Didier Rain; Y Najean
Induction of high-affinity GM-CSF receptors during all-trans retinoic acid treatment of acute promyelocytic leukemia.
Leukemia 1994;8(10):1758-62.
1994: O Blanchet; C Gazin; M L'Haridon; Z Tatari; Laurent Degos; F Sigaux; P Paul
Multiple nuclear factors bind to novel positive and negative regulatory elements upstream of the human MHC class I gene HLA-A11.
International immunology 1994;6(10):1485-96.
1994: C Dubois; Marie-Hélène Schlageter; A de Gentile; Nicole Balitrand; Marie-Elisabeth Toubert; I Krawice; Pierre Fenaux; Sylvie Castaigne; Y Najean; Laurent Degos
Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.
Leukemia 1994;8(10):1750-7.
1994: M Cornic; L Delva; Sylvie Castaigne; P Lefebvre; Nicole Balitrand; Laurent Degos; Christine Chomienne
In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Leukemia 1994;8(6):914-7.
1994: A Agadir; M Cornic; Bernard Gourmel; P Lefebvre; Laurent Degos; Christine Chomienne
Retinoic acid receptors: involvement in acute promyelocytic leukemia.
Cellular and molecular biology (Noisy-le-Grand, France) 1994;40(3):263-74.
1994: Fabien Guidez; W Huang; Jian-Hua Tong; C Dubois; Nicole Balitrand; Samuel Waxman; J L Michaux; P Martiat; Laurent Degos; Z Chen
Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.
Leukemia 1994;8(2):312-7.
1994: Z Chen; Fabien Guidez; Philippe Rousselot; A Agadir; Sai-Juan Chen; wang zhenyi; Laurent Degos; Arthur Zelent; Samuel Waxman; Christine Chomienne
PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(3):1178-82.
1994: Philippe Rousselot; bhushan hardas; A Patel; Fabien Guidez; Joop Gäken; Sylvie Castaigne; A Dejean; Hugues de Thé; Laurent Degos; Farzin Farzaneh
The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
Oncogene 1994;9(2):545-51.
1994: S Djoulah; Alicia Sanchez-Mazas; I Khalil; S Benhamamouch; Laurent Degos; I Deschamps; J Hors
HLA-DRB1, DQA1 and DQB1 DNA polymorphisms in healthy Algerian and genetic relationships with other populations.
Tissue antigens 1994;43(2):102-9.
1994: Laurent Degos
Differentiation therapy of leukemia.
Leukemia & lymphoma 1994;13 Suppl 1():39-43.
1994: Laurent Degos
Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survival.
Leukemia 1994;8 Suppl 2():S6-8.
1994: M Cornic; L Delva; Sylvie Castaigne; P Lefebvre; Nicole Balitrand; Laurent Degos; Christine Chomienne
In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Leukemia 1994;8 Suppl 2():S16-9.
1993: Laurent Degos
[From graft to histocompatibility].
Presse médicale (Paris, France : 1983) 1993;22(32):1511-4.
1993: L Delva; M Cornic; Nicole Balitrand; Fabien Guidez; J M Micléa; Alain Delmer; F Teillet; Pierre Fenaux; Sylvie Castaigne; Laurent Degos
Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells.
Blood 1993;82(7):2175-81.
1993: Marie-Thérèse Daniel; Marcel Koken; O Romagné; S Barbey; Ali Bazarbachi; M Stadler; Marie-Claude Guillemin; Laurent Degos; C Chomienne; Hugues de Thé
PML protein expression in hematopoietic and acute promyelocytic leukemia cells.
Blood 1993;82(6):1858-67.
1993: I Khalil; Sonia Berrih-Aknin; Virginia Lepage; M N Loste; P Gajdos; J Hors; Dominique Charron; Laurent Degos
Trans-encoded DQ alpha beta heterodimers confer susceptibility to myasthenia gravis disease.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(7):652-60.
1993: I Khalil; Sonia Berrih-Aknin; Virginia Lepage; M N Lost; P Gajdos; Dominique Charron; J Hors; Laurent Degos
Myasthenia gravis is associated with two DQ alpha/beta heterodimers.
Annals of the New York Academy of Sciences 1993;681():573-4.
1993: Laurent Degos
[Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].
Nouvelle revue française d'hématologie 1993;35(3):193-5.
1993: Laurent Degos
Annual guest lecture, Leukaemia Research Fund (UK): differentiation therapy and leukemia.
Leukemia 1993;7(5):766-72.
1993: I G Mansur; Gérald Leca; J C Pratt; Laurent Degos; Laurence Boumsell; Armand Bensussan
Identification of a novel functional 85-kD glycoprotein restricted to long-term dividing human lymphocytic lines.
Human immunology 1993;37(1):31-8.
1993: Hervé Dombret; M L Scrobohaci; P Ghorra; Jean-Marc Zini; Marie-Thérèse Daniel; Sylvie Castaigne; Laurent Degos
Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Leukemia 1993;7(1):2-9.
1993: Laurent Degos
All trans retinoic acid as a targeting drug for differentiation therapy in acute promyelocytic leukemia.
Cancer treatment and research 1993;64():1-13.
1992: S Djoulah; I Khalil; J P Beressi; S Benhamamouch; K Bessaoud; I Deschamps; Laurent Degos; J Hors
The HLA-DRB1*0405 haplotype is most strongly associated with IDDM in Algerians.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1992;19(6):381-9.
1992: Laurent Degos
[HLA and cancer].
Pathologie-biologie 1992;39(9):914-5.
1992: Laurent Degos
Approaches for an explanation of the differentiating effect of all trans retinoic acid in acute promyelocytic leukemia.
Leukemia 1992;6 Suppl 4():44-6.
1992: Sylvie Castaigne; Nicole Balitrand; Hugues de Thé; A Dejean; Laurent Degos; Christine Chomienne
A PML/retinoic acid receptor alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia.
Blood 1992;79(12):3110-5.
1992: M Cornic; L Delva; Fabien Guidez; Nicole Balitrand; Laurent Degos; Christine Chomienne
Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients.
Cancer research 1992;52(12):3329-34.
1992: O Blanchet; J F Bourge; H Zinszner; Alain Israel; Philippe Kourilsky; Jean Dausset; Laurent Degos; P Paul
Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(8):3488-92.
1992: A Rocca; A Opolski; ANGELA SAMAAN; B Frangoulis; Laurent Degos; Marika Pla
Localization of the conformational alteration of MHC molecules induced by the association of mouse class I heavy chain with a xenogeneic beta 2-microglobulin.
Molecular immunology 1992;29(4):481-7.
1992: Hervé Dombret; M Hunault; C Faucher; M C Dombret; Laurent Degos
Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils.
Cancer 1992;69(6):1356-61.
1992: I Khalil; I Deschamps; Virginia Lepage; R al-Daccak; Laurent Degos; J Hors
Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility.
Diabetes 1992;41(3):378-84.
1992: Hervé Bachelez; Béatrice Flageul; Laurent Degos; Laurence Boumsell; Armand Bensussan
TCR gamma delta bearing T lymphocytes infiltrating human primary cutaneous melanomas.
The Journal of investigative dermatology 1992;98(3):369-74.
1992: Laurent Degos
All-trans-retinoic acid treatment and retinoic acid receptor alpha gene rearrangement in acute promyelocytic leukemia: a model for differentiation therapy.
International journal of cell cloning 1992;10(2):63-9.
1992: Laurent Degos
Retinoic acid in acute promyelocytic leukemia: a model for differentiation therapy.
Current opinion in oncology 1992;4(1):45-52.
1992: Laurent Degos; I Khalil; O Blanchet; Virginia Lepage; P Paul; J Hors
Molecular approaches to the relationships between HLA and susceptibility to diseases.
Advances in nephrology from the Necker Hospital 1992;21():13-22.
1992: M Cornic; Fabien Guidez; L Delva; A Agadir; Laurent Degos; Christine Chomienne
[Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
Bulletin du cancer 1992;79(7):697-704.
1991: P Lefebvre; G Thomas; Bernard Gourmel; A Agadir; Sylvie Castaigne; C Dreux; Laurent Degos; Christine Chomienne
Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.
Leukemia 1991;5(12):1054-8.
1991: A Rocca; Laurent Degos; Marika Pla
Analysis of primary HLA-specific cytotoxic T cell response in graft-draining lymph nodes--a transgenic mouse model for in vivo recognition of human MHC antigens.
Transplantation 1991;52(6):1062-7.
1991: Christine Chomienne; Nicole Balitrand; P Ballerini; Sylvie Castaigne; Hugues de Thé; Laurent Degos
All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.
The Journal of clinical investigation 1991;88(6):2150-4.
1991: I Khalil; Virginia Lepage; Corinne Douay; L Morin; R al-Daccak; D Wallach; O Binet; F Lemarchand; Laurent Degos; J Hors
HLA DQB1*0301 allele is involved in the susceptibility to erythema multiforme.
The Journal of investigative dermatology 1991;97(4):697-700.
1991: A Rocca; ANGELA SAMAAN; C Michel; D Besluau; Laurent Degos; Marika Pla
H-2 influence on the production of real but not of apparent H-2-specific antibodies induced by the association of syngeneic class I heavy chains with bovine beta 2-microglobulin.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1991;18(5-6):367-78.
1991: O Blanchet; J F Bourge; H Zinszner; Z Tatari; Laurent Degos; P Paul
DNA binding of regulatory factors interacting with MHC-class-I gene enhancer correlates with MHC-class-I transcriptional level in class-I-defective cell lines.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1991;6():138-45.
1991: M Reboul; B Frangoulis; A Rocca; Laurent Degos; Marika Pla
Recognition of HLA-B27 by mouse cytotoxic T-cell clones: a transgenic mouse model.
Immunogenetics 1991;34(3):196-200.
1991: Christine Chomienne; M Cornic; Sylvie Castaigne; P Lefebvre; Hugues de Thé; A Dejean; Laurent Degos
[Biological parameters of the efficiency of retinoic acid in acute leukemia].
Comptes rendus des séances de la Société de biologie et de ses filiales 1991;185(6):456-63.
1991: I Kalidi; N Pellerain; M Masset; S Matonnière; Françoise Valensi; M F Dagay; Pauline Brice; Laurent Degos; G Delsol; J Hors
Production of a monoclonal antibody (2B44) reactive on a shared epitope on dendritic reticulum cells, smooth muscle cells of vessels and Reed-Sternberg cells.
Nouvelle revue française d'hématologie 1991;33(6):533-9.
1991: Hervé Dombret; Marie-Elisabeth Toubert; Marie-Hélène Schlageter; Christine Chomienne; Laurent Degos
Granulocytic colony-stimulating factors (G-CSF and GM-CSF) in the treatment of adult acute myeloid leukemia.
Nouvelle revue française d'hématologie 1991;33(6):445-8.
1991: Laurent Degos
Phenotypic reversion in acute promyelocytic leukemia.
Nouvelle revue française d'hématologie 1991;33(6):511-5.
1990: Christine Chomienne; P Ballerini; Nicole Balitrand; M E Huang; I Krawice; Sylvie Castaigne; Pierre Fenaux; P Tiollais; A Dejean; Laurent Degos
The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias.
Leukemia 1990;4(12):802-7.
1990: Christine Chomienne; P Ballerini; Nicole Balitrand; Marie-Thérèse Daniel; Pierre Fenaux; Sylvie Castaigne; Laurent Degos
All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship.
Blood 1990;76(9):1710-7.
1990: Béatrice Flageul; J M Miclea; Armand Bensussan; Laurent Degos
[Immunotherapy of malignant melanoma].
Pathologie-biologie 1990;38(8):881-2.
1990: Laurent Degos
[HLA complex and susceptibility to insulin-dependent diabetes].
Presse médicale (Paris, France : 1983) 1990;19(28):1303-4.
1990: I Khalil; L d'Auriol; M Gobet; L Morin; Virginia Lepage; I Deschamps; M S Park; Laurent Degos; Francis Galibert; J Hors
A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus.
The Journal of clinical investigation 1990;85(4):1315-9.
1990: R al-Daccak; Pascale Loiseau; A Soulie; F Varrin; C Rabian; Colette Raffoux; D Cohen; Laurent Degos; Eliane Gluckman; J Colombani
HLA-DP genotyping in HLA-A,B, and DR identical intrafamilial bone marrow transplantation.
Leukemia 1990;4(3):222-6.
1990: H Zinszner; M Masset; J F Bourge; J Colombani; D Cohen; Laurent Degos; P Paul
Nucleotide sequence of the HLA-A26 class I gene: identification of specific residues and molecular mapping of public HLA class I epitopes.
Human immunology 1990;27(3):155-66.
1990: Hervé Tilly; Sylvie Castaigne; Dominique Bordessoule; Philippe Casassus; Pierre-Yves Le Prisé; G Tertian; Bernard Desablens; Michel Henry-Amar; Laurent Degos
Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(2):272-9.
1990: Béatrice Flageul; Hervé Bachelez; Laurence Boumsell; Laurent Degos; Armand Bensussan
Infiltrating lymphocytes in benign and malignant naevomelanocytic lesions.
Nouvelle revue française d'hématologie 1990;32(1):9-11.
1990: I Khalil; L d'Auriol; L Morin; M Gobet; Virginia Lepage; Francis Galibert; Laurent Degos; J Hors
Typing for HLA DQ using oligonucleotidic probes.
Nouvelle revue française d'hématologie 1990;32(1):109-12.
1990: J C Bories; Pascale Loiseau; L d'Auriol; C Gontier; Armand Bensussan; Laurent Degos; François Sigaux
Regulation of transcription of the human T cell antigen receptor delta chain gene. A T lineage-specific enhancer element is located in the J delta 3-C delta intron.
The Journal of experimental medicine 1990;171(1):75-83.
1990: Laurent Degos
Differentiating agents in the treatment of leukemia and myelodysplastic syndromes.
Leukemia research 1990;14(8):731-3.
1990: Laurent Degos
Differentiating agents in the treatment of leukemia.
Leukemia research 1990;14(8):717-9.
1990: Sylvie Castaigne; Christine Chomienne; Marie-Thérèse Daniel; Roland Berger; J M Miclea; P Ballerini; Laurent Degos
Retinoic acids in the treatment of acute promyelocytic leukemia.
Nouvelle revue française d'hématologie 1990;32(1):36-8.
1990: Christine Chomienne; P Ballerini; M Huang; M Cornic; J P Abita; Sylvie Castaigne; Laurent Degos
In vitro effects of retinoic acid.
Nouvelle revue française d'hématologie 1990;32(1):32-4.
1990: violaine david; Hervé Bachelez; Gérald Leca; Laurent Degos; Laurence Boumsell; Armand Bensussan
Identification of a novel 110-kilodalton structure expressed on a subset of T cell receptor-gamma delta-bearing cloned lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(1):1-6.
1990: I Khalil; I Deschamps; Virginia Lepage; L Morin; Francis Galibert; Laurent Degos; J Hors
HLA DQ alpha/beta molecule associated with the susceptibility to insulin-dependent diabetes mellitus. A model for HLA/autoimmune disease association.
Nouvelle revue française d'hématologie 1990;32(6):445-7.
1989: Laurent Degos
[New perspectives in the treatment of cancer].
Pathologie-biologie 1989;37(9):979-80.
1989: Christine Chomienne; P Ballerini; Nicole Balitrand; M Amar; J F Bernard; P Boivin; Marie-Thérèse Daniel; Roland Berger; Sylvie Castaigne; Laurent Degos
Retinoic acid therapy for promyelocytic leukaemia.
Lancet 1989;2(8665):746-7.
1989: Christine Chomienne; G Thomas; Y Najean; Laurent Degos
[Refractory anemia with partial blastosis. A new therapeutic approach].
Presse médicale (Paris, France : 1983) 1989;18(23):1159-63.
1989: Armand Bensussan; J F Lagabrielle; Laurent Degos
TCR gamma delta bearing lymphocyte clones with lymphokine-activated killer activity against autologous leukemic cells.
Blood 1989;73(8):2077-80.
1989: R Kraïba; Pascale Loiseau; A Faille; O Poirier; D Piatier-Tonneau; Laurent Degos; J P Abita; Dominique Charron
HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies.
Leukemia 1989;3(5):386-93.
1989: ANGELA SAMAAN; D Gillet; M Chopin; Laurent Degos; Marika Pla
Mouse cytotoxic T cells can recognize HLA-B27 antigen without H-2 restriction.
Immunogenetics 1989;29(3):210-2.
1989: A Rocca; A Opolski; B Frangoulis; Laurent Degos; Marika Pla
Real and apparent H-2-specific antibodies induced by syngeneic immunization.
Immunogenetics 1989;30(4):303-6.
1989: Sylvie Castaigne; François Sigaux; Laurent Degos; G Flandrin
Hairy cell leukemia: follow-up after completion of alpha interferon treatment.
Nouvelle revue française d'hématologie 1989;31(5):321-5.
1989: Armand Bensussan; J F Lagabrielle; Sylvie Castaigne; N Boisson; J M Miclea; Marc Benbunan; Laurent Degos
Human CD3 gamma delta + activated lymphocytes exhibit killer activity in vitro against autologous leukemic cells.
Nouvelle revue française d'hématologie 1989;31(2):129-32.
1989: A Rocca; D Besluau; Virginia Lepage; J Colombani; Laurent Degos; Marika Pla
Xenogeneic monoclonal HLA-specific antibodies defining mouse lymphocyte determinants encoded by the H-2 complex.
Immunogenetics 1989;29(6):408-10.
1988: M P Font; Z Chen; J C Bories; N Duparc; Pascale Loiseau; Laurent Degos; H Cann; D Cohen; Jean Dausset; François Sigaux
The V gamma locus of the human T cell receptor gamma gene. Repertoire polymorphism of the first variable gene segment subgroup.
The Journal of experimental medicine 1988;168(4):1383-94.
1988: Virginia Lepage; Corinne Douay; C Mallet; O Binet; F Lemarchand; D Wallach; M Masset; J Colombani; Laurent Degos
Erythema multiforme is associated to HLA-Aw33 and DRw53.
Tissue antigens 1988;32(3):170-5.
1988: E Vilmer; P Guglielmi; violaine david; Gérald Leca; C Rabian; Laurent Degos; M Boiron; Armand Bensussan
Predominant expression of circulating CD3+ lymphocytes bearing gamma T cell receptor in a prolonged immunodeficiency after allogeneic bone marrow transplantation.
The Journal of clinical investigation 1988;82(3):755-61.
1988: E Vilmer; F Triebel; violaine david; C Rabian; M Schumpp; Gérald Leca; Laurent Degos; T Hercend; François Sigaux; Armand Bensussan
Prominent expansion of circulating lymphocytes bearing gamma T-cell receptors, with preferential expression of variable gamma genes after allogeneic bone marrow transplantation.
Blood 1988;72(3):841-9.
1988: B Frangoulis; M Chopin; D Besluau; Laurent Degos; Marika Pla
Immune response to H-2 class I antigens on platelets. II. Specific decrease of H-2 class I-specific antibody response induced by treatment with allogeneic platelets.
Tissue antigens 1988;32(2):78-86.
1988: Z Chen; M P Font; Pascale Loiseau; J C Bories; Laurent Degos; Marie-Paule Lefranc; François Sigaux
The human T-cell V gamma gene locus: cloning of new segments and study of V gamma rearrangements in neoplastic T and B cells.
Blood 1988;72(2):776-83.
1988: B Frangoulis; D Besluau; M Chopin; Laurent Degos; Marika Pla
Immune response to H-2 class I antigens on platelets. I. Immunogenicity of platelet class I antigens.
Tissue antigens 1988;32(1):46-54.
1988: Martine Amiot; Hélène Dastot; Laurent Degos; Jean Dausset; Alain Bernard; Laurence Boumsell
HLA class I molecules are associated with CD1a heavy chains on normal human thymus cells.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(12):4451-4.
1988: Martine Amiot; Hélène Dastot; M Fabbi; Laurent Degos; Alain Bernard; Laurence Boumsell
Intermolecular complexes between three human CD1 molecules on normal thymus cells.
Immunogenetics 1988;27(3):187-95.
1988: Laurent Degos
[Treatment of malignant tumors by interleukin 2 and LAK cells].
Nouvelle revue française d'hématologie 1988;30(1-2):119-22.
1988: Sylvie Castaigne; Liliane Dal Cortivo; Guy Leverger; J M Miclea; Eric Lepage; Marc Benbunan; Jean Gerota; Laurent Degos; M Boiron
[Autografts of blood cells at various stages].
Nouvelle revue française d'hématologie 1988;30(1-2):69-73.
1988: D Gillet; Etienne Mornet; A Rocca; Laurent Degos; D Cohen; Marika Pla
Extensive genomic polymorphism in mouse 21-hydroxylase region.
Immunogenetics 1988;27(2):133-6.
1987: G Flandrin; Sylvie Castaigne; François Sigaux; Laurent Degos
Results of treating 53 hairy cell leukemia patients with alpha-interferon.
Leukemia 1987;1(4):326-8.
1987: Christine Chomienne; R Emanoil-Ravier; Nicole Balitrand; M Garcette; Laurent Degos; J P Abita
Differential expression of c-myc and c-fos oncogenes during the differentiation of human leukemic cells by Ara-C.
Journal of biological regulators and homeostatic agents 1987;1(2):69-72.
1987: S Collado; Michel Marty; Marie-Thérèse Daniel; Jean-Luc Harousseau; Dominique Bordessoule; Jean-Marc Extra; Laurent Degos; G Schaisson; M Boiron
[Improved results in the treatment of acute monoblastic leukemia: analysis of 91 patients treated in the 01 AM 81 protocol].
Nouvelle revue française d'hématologie 1987;29(4):215-20.
1987: Christine Chomienne; Y Najean; Laurent Degos; G Thomas; E Baumelou; F Calvo; Philippe Casassus; F Ciccone; Pierre Fenaux; J C Gris
Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literature.
Acta haematologica 1987;78 Suppl 1():109-15.
1986: F Lemarchand-Venencie; V Lepace; S Belaich; J Civatte; C Rabian; A Chidiac; J Colombani; Laurent Degos
[HLA typing in classical and African Kaposi's disease].
Pathologie-biologie 1986;34(6):761-4.
1986: Sylvie Castaigne; F Calvo; L Douay; F Thomas; Marc Benbunan; Jean Gerota; Laurent Degos
Successful haematopoietic reconstitution using autologous peripheral blood mononucleated cells in a patient with acute promyelocytic leukaemia.
British journal of haematology 1986;63(1):209-11.
1985: Virginia Lepage; D Alcalay; Corinne Douay; C Mallet; P Loiseau; Laurent Degos; M Colombani; J Colombani
Evidence for a new HLA class II determinant present on cells from HLA-DR1 and/or -DR4 individuals.
Tissue antigens 1985;25(2):96-102.
1985: Armand Bensussan; J F Bourge; Ellis L Reinherz; Laurent Degos; Marilyne Sasportes
[Phorbol diester induces phenotypic and functional changes in human T-lymphocyte clones].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1985;301(4):121-4.
1983: L Guilherme; M Colombani; N Sansonetti; Laurent Degos; J Colombani
Studies on human Ia supertypic specificities by complement fixation on PHA blasts. I. Serological properties of DC1 specificity.
Revue française de transfusion et immuno-hématologie 1983;26(4):379-94.